UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 13.

Hetzenecker, A M; Seidl, M C; Kosovac, K; Herfarth, H; Kellermeier, S; Obermeier, F; Falk, W; Schoelmerich, J; Hausmann, M; Rogler, G (2012). Downregulation of the ubiquitin-proteasome system in normal colonic macrophages and reinduction in inflammatory bowel disease. Digestion, 86(1):34-47.

Hausmann, M; Leucht, K; Ploner, C; Kiessling, S; Villunger, A; Becker, H; Hofmann, C; Falk, W; Krebs, M; Kellermeier, S; Fried, M; Schölmerich, J; Obermeier, F; Rogler, G (2011). BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells. Journal of Biological Chemistry, 286(30):26533-26540.

Parolini, O; Alviano, F; Bergwerf, I; Boraschi, D; De Bari, C; De Waele, P; Dominici, M; Evangelista, M; Falk, W; Hennerbichler, S; Hess, D C; Lanzoni, G; Liu, B; Marongiu, F; Mc Guckin, C; Mohr, S; Nolli, M L; Ofir, R; Ponsaerts, P; Romagnoli, L; Solomon, A; Soncini, M; Strom, S; Surbek, D; Venkatachalam, S; Wolbank, S; Zeisberger, S M; Zeitlin, A; Zisch, A; Borlongan, C V (2010). Toward cell therapy using placenta-derived cells: Disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells and Development, 19(2):143-154.

Kosovac, K; Brenmoehl, J; Holler, E; Falk, W; Schoelmerich, J; Hausmann, M; Rogler, G (2010). Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients. Inflammatory Bowel Diseases, 16(8):1311-1321.

Bentz, S; Hausmann, M; Piberger, H; Kellermeier, S; Paul, S; Held, L; Falk, W; Obermeier, F; Fried, M; Schölmerich, J; Rogler, G (2010). Clinical relevance of IgG antibodies against food antigens in Crohn's disease: a double-blind cross-over diet intervention study. Digestion, 81(4):252-264.

Lang, M; Schlechtweg, M; Kellermeier, S; Brenmoehl, J; Falk, W; Schölmerich, J; Herfarth, H; Rogler, G; Hausmann, M (2009). Gene expression profiles of mucosal fibroblasts from strictured and nonstrictured areas of patients with Crohn's disease. Inflammatory Bowel Diseases, 15(2):212-223.

Blaas, S H; Stieber-Gunckel, M; Falk, W; Obermeier, F; Rogler, G (2009). CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells. Clinical and Experimental Immunology, 155(3):534-540.

Hofmann, C; Lippert, E; Falk, W; Schölmerich, J; Rogler, G; Obermeier, F (2009). Primary human colonic epithelial cells are transiently protected from anoikis by a Src-dependent mechanism. Biochemical and Biophysical Research Communications (BBRC), 390(3):908-914.

Brenmoehl, J; Miller, S N; Hofmann, C; Vogl, D; Falk, W; Schölmerich, J; Rogler, G (2009). Transforming growth factor-beta 1 induces intestinal myofibroblast differentiation and modulates their migration. World Journal of Gastroenterology, 15(12):1431-1442.

Brenmoehl, J; Falk, W; Göke, M; Schölmerich, J; Rogler, G (2008). Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF). International Journal of Colorectal Disease, 23(10):947-955.

Hausmann, M; Paul, G; Kellermeier, S; Frey, I; Schölmerich, J; Falk, W; Menzel, K; Fried, M; Herfarth, H; Rogler, G (2008). (GT)n Dinucleotide repeat polymorphism of haem oxygenase-1 promotor region is not associated with inflammatory bowel disease risk or disease course. Clinical and Experimental Immunology, 153(1):81-85.

Lippert, E; Gunckel, M; Brenmoehl, J; Bataille, F; Falk, W; Scholmerich, J; Obermeier, F; Rogler, G (2008). Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation. Clinical and Experimental Immunology, 152(2):285-297.

Hausmann, M; Paul, G; Menzel, K; Brunner-Ploss, R; Falk, W; Schölmerich, J; Herfarth, H; Rogler, G (2008). NAT1 genotypes do not predict response to mesalamine in patients with ulcerative colitis. Zeitschrift für Gastroenterologie, 46(3):259-265.

This list was generated on Sat Jul 29 15:13:26 2017 CEST.